AK

Ayyankandath Kuttan Manu

Active Director Director DIN 10849084
DIN 10849084 First appointment Nov 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ayyankandath Kuttan Manu

Data last updated:

Ayyankandath Kuttan Manu is a Director at Xelton Pharma Private Limited (since 2024).

DIN 10849084
Primary Designation Director
First Appointment 25 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xelton Pharma Private Limited U46497MH2024PTC435400
Director25 Nov 20242024Active

Board colleagues of Ayyankandath Kuttan Manu

Directorship timeline

Open interactive timeline →
Xelton Pharma Private Limited
Premium access

Shareholding and investment profile for Ayyankandath Kuttan Manu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayyankandath Kuttan Manu

Ayyankandath Kuttan Manu currently holds 1 directorship: Xelton Pharma Private Limited (Director, since 25 Nov 2024).

Ayyankandath Kuttan Manu was first appointed on 25 Nov 2024 as Director at Xelton Pharma Private Limited.

The current boards of Ayyankandath Kuttan Manu's companies include Abdul Asees (Xelton Pharma Private Limited), Nigin Unni Unninarayanan (Xelton Pharma Private Limited), Shaik Mohiyudheen (Xelton Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available